Seed VC · USA

Versant Ventures

Active

What they invest in

Versant harnesses in-house Discovery Engines—multidisciplinary scientist teams in state-of-the-art lab facilities—to enable the launch of novel biotechnology companies with academic founders.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers

Geography

US, Europe

The people who write checks

12 partners on file at Versant Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Versant Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Versant Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Sep 2017
Portfolio last checked
Oct 6, 2026
Website
www.versantventures.com ↗

Other firms investing in DeepTech

See all investors

Is Versant Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Versant Ventures is one of them, and we'll tell you exactly where they sit in your top 100.